Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
When the Biden administration renews the Covid public health emergency this week, it will mark the 11th time since the coronavirus arrived that the government declared its presence a national crisis. It may also be the last. Senior Biden officials are targeting an end to the emergency designation for Covid as soon as the spring, ...
Longtime Congressman Sen. Bernie Sanders, I-Vt., is expected next month to take the helm of the Senate’s Health, Education, Labor and Pensions Committee, bringing the Medicare-for-All proponent center stage in one of the nation’s most broadly influential health policy forums. The anticipated appointment comes after the current committee chair Sen. Patty Murray, D-Wash., announced that ...
Controlled substances became a little less controlled during the pandemic. That benefited both patients (for their health) and telehealth startups (to make money). Some potentially addictive medications — like buprenorphine and Adderall — are now far more available online to patients because of regulatory changes. Given the scarcity of qualified doctors to treat some of ...
In 2026, the Inflation Reduction Act (IRA) will allow the Centers for Medicare and Medicaid Services (CMS) to negotiate the maximum price of certain prescription drugs on behalf of Medicare beneficiaries for the first time in the history of the program. While the IRA specifies the criteria for selecting drugs eligible for negotiations—brand-name drugs that do not ...
The National Association of Health Underwriters (NAHU), the preeminent organization for health insurance and employee benefits professionals, is rebranding as the National Association of Benefits and Insurance Professionals (NABIP).
Drugmakers including Pfizer Inc (PFE.N), GlaxoSmithKline PLC (GSK.L), Bristol Myers Squibb (BMY.N), AstraZeneca PLC (AZN.L) and Sanofi SA (SASY.PA) plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors.
Need medical treatment this year and want to nail down your out-of-pocket costs before you walk into the doctor’s office? There’s a new tool for that, at least for insured patients. As of Jan. 1, health insurers and employers that offer health plans must provide online calculators for patients to get detailed estimates of what ...
Health care lobbyists representing insurers, drugmakers and a range of powerful industry interests are steeling themselves for a Senate chair immune to their usual charms — Bernie Sanders. The Vermont independent is set to take over the Senate’s Health, Education, Labor and Pensions Committee next month. Leading the panel gives the Medicare-for-All proponent oversight authority ...
Just ahead of the year-end deadline, President Joe Biden signed into law a massive $1.7 trillion spending package that includes a slew of healthcare policy priorities. Biden signed the bill late on Dec. 29 after it was flown to him while vacationing during the holidays in the U.S. Virgin Islands, the White House said. In ...
On Thursday night, President Joe Biden signed the $1.7 trillion omnibus spending package which contains the SECURE 2.0 Act—a package of retirement reform that will have widespread implications for the industry and will increase the savings potential for many Americans. The Senate passed the spending bill 68 to 29 on December 22, and the House ...